PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 29 filers reported holding PROVENTION BIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $434,000 | +5.1% | 41,400 | +69.7% | 0.02% | -15.8% |
| Q4 2020 | $413,000 | +31.9% | 24,400 | 0.0% | 0.02% | +18.8% |
| Q3 2020 | $313,000 | -9.0% | 24,400 | 0.0% | 0.02% | -15.8% |
| Q2 2020 | $344,000 | -11.8% | 24,400 | -42.5% | 0.02% | -32.1% |
| Q1 2020 | $390,000 | -47.9% | 42,400 | -15.7% | 0.03% | -33.3% |
| Q4 2019 | $749,000 | +98.7% | 50,300 | -9.0% | 0.04% | +82.6% |
| Q3 2019 | $377,000 | -22.4% | 55,300 | +37.6% | 0.02% | -23.3% |
| Q2 2019 | $486,000 | – | 40,199 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS LLC | 116,324 | $2,803,407 | 0.00% |